moderna stock jumped by double digits tuesday on positive news about its cancer vaccine but chardan capital markets believes the biotech company’s shares won’t go much higher moderna ticker mrna and merck mrk said on tuesday that using moderna ‘s experimental cancer vaccine with merck ‘s keytruda in melanoma patients reduced the risk of death in a phase 2 trial modern’s stock jumped 20 to close at 19754